NM_000046.5:c.430G>A
Variant summary
Our verdict is Pathogenic. The variant received 21 ACMG points: 21P and 0B. PS1PM1PM2PP2PP3_StrongPP5_Very_Strong
The NM_000046.5(ARSB):c.430G>A(p.Gly144Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,614,026 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 14/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Pathogenic in ClinVar. Synonymous variant affecting the same amino acid position (i.e. G144G) has been classified as Likely benign.
Frequency
Consequence
NM_000046.5 missense
Scores
Clinical Significance
Conservation
Publications
- mucopolysaccharidosis type 6Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Genomics England PanelApp, Illumina, Labcorp Genetics (formerly Invitae), G2P, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 21 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ARSB | NM_000046.5 | c.430G>A | p.Gly144Arg | missense_variant | Exon 2 of 8 | ENST00000264914.10 | NP_000037.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ARSB | ENST00000264914.10 | c.430G>A | p.Gly144Arg | missense_variant | Exon 2 of 8 | 1 | NM_000046.5 | ENSP00000264914.4 | ||
| ARSB | ENST00000396151.7 | c.430G>A | p.Gly144Arg | missense_variant | Exon 3 of 8 | 1 | ENSP00000379455.3 | |||
| ARSB | ENST00000565165.2 | c.430G>A | p.Gly144Arg | missense_variant | Exon 2 of 5 | 1 | ENSP00000456339.2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152142Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000795 AC: 2AN: 251460 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461884Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727248 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152142Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74320 show subpopulations
ClinVar
Submissions by phenotype
Mucopolysaccharidosis type 6 Pathogenic:5
In vitro functional studies supportive of a damaging effect on the gene product (low to no ARSB activity in homozygotes; PS3); Very low frequency in ExAC (PM2) -
- -
- -
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 144 of the ARSB protein (p.Gly144Arg). This variant is present in population databases (rs746206847, gnomAD 0.004%). This missense change has been observed in individual(s) with mucopolysaccharidosis type VI (PMID: 8116615, 16435196, 26909334, 30982216). ClinVar contains an entry for this variant (Variation ID: 559783). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ARSB protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects ARSB function (PMID: 8116615). For these reasons, this variant has been classified as Pathogenic. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at